Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis B Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04201808
What this trial is testing

Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

Who this might be right for
Hepatitis B, Chronic
New Discovery LLC 100
Not applicableStudy completedNCT00397540
What this trial is testing

The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, HepatocellularChronic Hepatitis B
Seoul National University Hospital 145
Not applicableLooking for participantsNCT05195450
What this trial is testing

TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

Who this might be right for
Non-cirrhotic, Chronic Hepatitis B
Institute of Liver and Biliary Sciences, India 200
Post-approval studies (Phase 4)UnknownNCT01529255
What this trial is testing

EFFORT Extension Study

Who this might be right for
Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University 576
Post-approval studies (Phase 4)WithdrawnNCT00606099
What this trial is testing

Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Testing effectiveness (Phase 2)UnknownNCT05256823
What this trial is testing

Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B

Who this might be right for
To Evaluate the Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues in Nucleos(t)Ide-treated Patients With Chronic Hepatitis B
Lai Wei 47
Not applicableUnknownNCT06865859
What this trial is testing

Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients

Who this might be right for
HBV Related Acute-on-chronic Liver Failure
Qilu Hospital of Shandong University 21
Testing effectiveness (Phase 2)Study completedNCT01037062
What this trial is testing

An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 282
Not applicableLooking for participantsNCT05661786
What this trial is testing

Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 4,500
Not applicableEnded earlyNCT02128503
What this trial is testing

Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease

Who this might be right for
Inflammatory Bowel DiseaseCrohn DiseaseUlcerative Colitis+2 more
Chinese University of Hong Kong 430
Post-approval studies (Phase 4)UnknownNCT04584242
What this trial is testing

Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

Who this might be right for
Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
Yonsei University 40
Testing effectiveness (Phase 2)Study completedNCT01524679
What this trial is testing

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

Who this might be right for
Chronic Hepatitis B
Johannes Gutenberg University Mainz 170
Post-approval studies (Phase 4)Study completedNCT01264354
What this trial is testing

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Bukwang Pharmaceutical 60
Testing effectiveness (Phase 2)WithdrawnNCT04046107
What this trial is testing

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Who this might be right for
Hepatitis B Virus
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Study completedNCT02360592
What this trial is testing

Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Tongji Hospital 94
Very early researchUnknownNCT04507607
What this trial is testing

Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis BMother-to-child BlockAntiviral Treatment
Third Affiliated Hospital, Sun Yat-Sen University 50
Large-scale testing (Phase 3)Study completedNCT00362635
What this trial is testing

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

Who this might be right for
Hepatitis B
Bukwang Pharmaceutical 92
Testing effectiveness (Phase 2)Study completedNCT03685708
What this trial is testing

HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
HepatitisSafety and Tolerability
National Heart, Lung, and Blood Institute (NHLBI) 78
Large-scale testing (Phase 3)Study completedNCT00140725
What this trial is testing

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 160
Testing effectiveness (Phase 2)Ended earlyNCT03932513
What this trial is testing

Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients

Who this might be right for
HBVHepatitis BHepatitis B, Chronic
F-star Therapeutics, Inc. 8
Next Page